Enhanced Games Parent Company to Go Public in $1.2B SPAC Deal, Fueling Sports Controversy

NEW YORK, NY – February 12, 2026 – Enhanced Ltd., the provocative company planning a sporting event with no drug testing, today announced it has filed a registration statement with the U.S. Securities and Exchange Commission, moving a crucial step closer to becoming a publicly traded company on the New York Stock Exchange.

The filing is part of a planned business combination with A Paradise Acquisition Corp. (NASDAQ: APAD), a special purpose acquisition company (SPAC). The deal values the combined entity, which will be renamed Enhanced Group Inc. and trade under the ticker “ENHA,” at an enterprise value of $1.2 billion. This move injects a volatile and ethically charged debate over performance-enhancing drugs directly into the public financial markets.

Enhanced Ltd. is the parent company of the Enhanced Games, a proposed international sporting event that openly allows athletes to use performance-enhancing substances. The company’s public filing signals a bold bet that investor appetite for disruptive models and the public’s fascination with peak human performance will override the fierce opposition from the global sports establishment.

A High-Stakes Bet on a New Sporting Universe

The SPAC merger is expected to provide Enhanced with up to $200 million in gross cash proceeds, assuming no redemptions by A Paradise's current shareholders. This capital is earmarked for athlete recruitment, production of the inaugural Games, and building out the company's medical and consumer product infrastructure. The transaction comes on the heels of a separate $40 million private equity placement, indicating significant private backing for the controversial venture.

However, the company's own S-4 filing with the SEC acknowledges the immense risks involved. The document highlights Enhanced's “unproven business model, limited operating history, and minimal revenue to date.” It also lists a formidable array of challenges, including “public, medical, regulatory, and ethical scrutiny of performance-enhancement substances,” intense competition from established sports leagues, and potential legal action.

The valuation of $1.2 billion for a pre-revenue company operating in such a contentious space underscores the high-risk, high-reward nature of the investment. The SPAC route provides a faster path to public markets than a traditional IPO, a strategy often favored by ventures with disruptive but unproven concepts. The deal structure includes a dual-class share system, granting certain insiders disproportionate voting power.

'The Olympics on Steroids' vs. The World

At the heart of the controversy is The Enhanced Games, founded by Australian entrepreneur Dr. Aron D'Souza. Scheduled for May 24, 2026, at Resorts World Las Vegas, the event plans to feature swimming, track and field, and weightlifting. Its core premise is a direct challenge to the anti-doping philosophy that has governed mainstream sports for decades.

Organizers argue they are championing scientific innovation and athlete autonomy under a “body, your choice” philosophy. They claim the Games will be safer than traditional sports because enhancement will occur under rigorous medical supervision, with athletes undergoing health screenings and working with clinicians. The venture has attracted support from prominent investors, including venture capitalist Peter Thiel and Donald Trump Jr.'s 1789 Capital fund, who see it as a forward-thinking challenge to a stagnant status quo.

This vision has been met with condemnation from the world's leading sports authorities. The World Anti-Doping Agency (WADA) has labeled the idea “ridiculous” and “very dangerous.” The International Olympic Committee (IOC) stated it would “destroy any concept of fair play,” and World Aquatics called the event a “circus” built on shortcuts, vowing to ban any affiliated individuals from its own competitions. Critics are deeply concerned about the long-term health consequences for athletes and the message it sends to younger generations, potentially normalizing the use of powerful drugs in pursuit of athletic glory.

Despite the backlash, the Enhanced Games has successfully recruited several former elite athletes, including former Olympic swimmers, enticed by the promise of significant prize money and the freedom to push their biological limits without fear of sanctions.

Beyond the Arena: A 'Performance Medicine' Empire

Enhanced Group's ambitions extend beyond the athletic field. A core component of its business strategy is a direct-to-consumer division focused on “Performance Medicine.” This segment aims to market and sell products and telehealth services designed to optimize health, performance, and longevity for the general public.

Offerings are expected to include personalized treatments such as Testosterone Replacement Therapy (TRT) protocols and other prescription-based therapies, facilitated through online clinical consultations and blood testing. By positioning itself as a leader in the burgeoning biohacking and wellness markets—a sector projected to exceed $50 billion globally by 2034—the company hopes to build a sustainable revenue stream independent of the Games themselves.

This dual model presents its own set of regulatory hurdles. The company will need to navigate the complex legal landscape of telehealth services, data privacy, and the marketing of dietary supplements and prescription protocols. While the market for such products is growing, it is also under increasing scrutiny from regulators regarding safety, efficacy, and marketing claims.

As the SEC reviews the registration statement and shareholders of A Paradise Acquisition Corp. prepare to vote, Enhanced Group Inc. is poised at a critical juncture. The company is not only asking investors to buy into its stock but to endorse a radical vision for the future of sport and human potential. Its journey to the NYSE will be a closely watched test of whether Wall Street and the wider public are ready to embrace a world where the line between natural talent and scientific enhancement is deliberately erased.